Skip to main content

Table 2 Baseline characteristics of the subjects according to follow-up outcomes

From: Triglyceride and glucose (TyG) index as a predictor of incident hypertension: a 9-year longitudinal population-based study

Variables

Subjects developed HTN (n = 2047)

Subjects did not develop HTN (n = 2639)

p

TyG

8.55 (8.20–8.92)

8.23 (7.92–8.59)

< 0.001

Gender (male/female, n)

1541/506

1636/1003

< 0.001

Age (years)

44.0 (36.0–54.0)

38.0 (33.0–46.0)

< 0.001

BMI (kg/m2)

23.6 (21.8–25.4)

21.7 (19.8–23.6)

< 0.001

SBP (mmHg)

124.0 (117.0–131.0)

112.0 (105.0–120.0)

< 0.001

DBP (mmHg)

80.0 (75.0–84.0)

71.0 (67.0–76.0)

< 0.001

WC (cm)

81.0 (75.0–87.0)

75.0 (69.0–81.0)

< 0.001

BUN (μmol/L)

5.09 (4.29–5.96)

4.86 (4.15–5.66)

< 0.001

Cr (μmol/L)

74.0 (64.0–83.0)

71.0 (60.0–80.0)

< 0.001

FPG (mmol/L)

4.53 (4.21–4.89)

4.37 (4.09–4.66)

< 0.001

UA (μmol/L)

342.0 (284.0–395.0)

306.0 (250.0–364.0)

< 0.001

AST (U/L)

20.0 (17.0–25.0)

19.0 (16.0–23.0)

< 0.001

ALT (U/L)

25.0 (17.0–37.0)

20.0 (15.0–30.0)

< 0.001

γ-GGT (U/L)

21.0 (15.0–34.0)

16.0 (11.0–24.0)

< 0.001

TC (mmol/L)

4.83 (4.28–5.50)

4.56 (3.99–5.14)

< 0.001

TG (mmol/L)

1.38 (1.01–2.02)

1.07 (0.80–1.51)

< 0.001

HDL-C (mmol/L)

1.26 (1.07–1.52)

1.27 (1.08–1.58)

0.020

LDL-C (mmol/L)

2.73 (2.24–3.29)

2.51 (2.04–3.03)

< 0.001

Apo-A1 (g/L)

1.29 (1.13–1.50)

1.30 (1.13–1.48)

0.815

Apo-B (g/L)

0.97 (0.81–1.14)

0.85 (0.71–1.01)

< 0.001

eGFR (mL/(min·1.73 m2))

108.0 (95.0–122.0)

111.6 (100.2–126.2)

< 0.001